Genasys (GNSS) Director Granted 6,411 Shares; Now Owns 68,201

Genasys Inc. director W. Craig Fugate received 6,411 shares of the company's common stock on 10/01/2025 as payment in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025.

Rhea-AI Filing Summary

Genasys Inc. director W. Craig Fugate received 6,411 shares of the company's common stock on 10/01/2025 as payment in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025. After the grant, Mr. Fugate beneficially owns 68,201 shares. The shares were valued by dividing the cash retainer by the closing price on the grant date; the transaction was reported on Form 4 and signed by an attorney-in-fact on 10/03/2025.

Insider Trade Summary

Grant/Award: 6,411 shares

Grant/Award 1 txn

Insider Fugate William Craig

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,411	$0.00	$0.00

Holdings After Transaction: Common Stock — 68,201 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the GNSS Form 4 filed by W. Craig Fugate report?

The Form 4 reports a grant of 6,411 common shares to director W. Craig Fugate on 10/01/2025, issued in lieu of an accrued cash retainer.

How many GNSS shares does W. Craig Fugate own after the transaction?

Following the reported transaction, Mr. Fugate beneficially owns 68,201 shares of Genasys common stock.

Why were the 6,411 GNSS shares issued to the director?

The shares were granted in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025, with the number determined by the cash value divided by the closing stock price on the grant date.

When was the Form 4 for this GNSS transaction signed and filed?

The Form 4 shows an authorized signature by an attorney-in-fact on 10/03/2025 and lists the transaction date as 10/01/2025.

Did the Form 4 disclose any option exercises or derivative transactions for GNSS?

No. The Form 4 discloses only a non-derivative grant of 6,411 common shares; no derivative securities were reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Fugate William Craig

(Last) (First) (Middle)

16262 WEST BERNARDO DRIVE

(Street)

SAN DIEGO CA 92127

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genasys Inc. [ GNSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		6,411	A	$0	68,201	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.

	/s/ Cassandra Monteon as attorney-in-fact for W. Craig Fugate	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.